Cosmo Shares Soar Most in 17 Years on Hair-Loss Treatment Data
Cosmo Pharmaceuticals NV shares soared the most in 17 years after the company said its experimental treatment for male hair loss showed breakthrough results in two late-stage studies.
By Lisa Pham · Bloomberg Markets
Cosmo Pharmaceuticals NV shares soared the most in 17 years after the company said its experimental treatment for male hair loss showed breakthrough results in two late-stage studies.